-The in vitro effects of 2 representative mycotoxins, T-2 toxin and deoxynivalenol (DON), of trichothecene group on the electron transport system (ETS) of mitochondria in rat cardiomyocytes were investigated by measuring oxygen consumption rates (OCR). The ATP-linked OCR and the reserve capacity (RC) of the mitochondria ETS were quantified by a "mitochondria stress test" which was estimated by the OCR responses to oligomycin and carbonyl cyanide-p-trifluoromethoxyphenylhydrazone, with an extracellular flux analyzer. The basal OCR was significantly inhibited by the application of T-2 toxin at concentrations of 6 × 10 -1 to 6 × 10 -5 μM and DON at concentrations of 0.78 to 100 μM for 24 hr. The threshold of cardiomyocyte toxicity was estimated to be between 6.0 × 10 -6 and 6.0 × 10 -5 μM for T-2 toxicity on both ATP-linked OCR and RC and between 0.39 and 0.78 μM on ATP-linked OCR or between 1.56 and 3.13 μM on RC for DON. The decrease in OCR of cardiomyocytes exposed to T-2 toxin with a concentration of 6.0 × 10 -3 and 6.0 × 10 -4 μM was significantly inhibited by antioxidants, catalase and vitamin C. In conclusion, the present study demonstrated, through the direct and real-time measurement of respiratory function in mitochondria, that a marked inhibition of mitochondrial ETS function in cardiomyocytes was induced by T-2 toxin and DON and that the mitochondrial dysfunction by T-2 toxin was largely associated with oxidative stress.
-This study aimed to determine the cardiac and autonomic nervous effects of deoxynivalenol (DON), a representative mycotoxin which frequently contaminates cereal grains, in conscious rats that had been implanted with telemetric transmitters. Four groups of rats given subcutaneous injections of 0.5, 1.0, or 2.0 mg/kg of DON or propylene glycol (vehicle solution) were used in the experiments. Telemetric electrocardiogram (ECG) recordings were performed for 2 weeks or longer during the pre-and post-DON injection period. The present study demonstrated that DON caused marked arrhythmias, such as second-degree atrioventricular block, atrial bradycardia, supraventricular extrasystole, and ventricular extrasystole, at 3 hr or later (mostly at 10-20 hr) after the DON-injection, which were accompanied by a significant increase in heart rate (HR) and a significant decrease in total power and low-and highfrequency power during the period from 90 to 180 min after the injection. In conclusion, it was elucidated that DON produces significant cardiac dysfunction and transient inhibition of the autonomic nervous function in conscious rats at a dose of 0.5 mg/kg s.c. or more.
This study was conducted to clarify and reevaluate the cardiac and autonomic nervous effects of T-2 toxin, which had been previously examined by several acute experiments, in unrestrained and conscious rats implanted with telemetric transmitters. Two groups of rats were given two subcutaneous injections of 0.1 and 0.5 mg/kg of T-2 toxin with an interval of 3 days. Two other groups of rat were pre-implanted with osmotic minipumps by which atropine (20 mg/kg/day) or propranolol (100 mg/kg/day) was continuously administered preceding subcutaneous injection of T-2 toxin (0.5 mg/kg). The present study demonstrated that T-2 toxin caused marked arrhythmias, such as second-degree atrioventricular (AV) block, sinus bradycardia, supraventricular extrasystole, and ventricular extrasystole, which were accompanied by a significant increase in heart rate and a significant decrease in total power and low- and high-frequency power of heart rate variability, during 3 days of observation after the toxin administration. However, the occurrence of arrhythmia with conduction disturbance such as second-degree atrioventricular blocks was markedly diminished by pretreatment with atropine, while the occurrence of ventricular extrasystole was augmented by atropine. The present study with the telemetric measurement elucidated and confirmed that T-2 toxin produced significant cardiac dysfunctions involving disturbance of the conduction pathway influenced by the autonomic nervous activity and also possible direct effects on cardiac myocytes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.